| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/16/1993 | WO1993018023A1 Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 09/16/1993 | WO1993018003A1 Substitued pipecolinic acid derivatives as hiv protease inhibitors |
| 09/16/1993 | WO1993017717A1 Compositions and methods for modulating rna |
| 09/16/1993 | WO1993017684A2 Enantiomeric hydroxylated xanthine compounds |
| 09/16/1993 | WO1993017672A1 Treatment of migraine |
| 09/16/1993 | CA2131389A1 Thrombin receptor antagonists |
| 09/16/1993 | CA2131381A1 Nitrogen containing heterocyclic compounds useful as pharmaceuticals |
| 09/16/1993 | CA2131010A1 Cyclic ketal derivatives |
| 09/16/1993 | CA2130938A1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 09/16/1993 | CA2130359A1 Compositions and methods for modulating rna |
| 09/16/1993 | CA2129145A1 Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 09/15/1993 | EP0560723A1 Method and composition for the treatment of osteoporosis |
| 09/15/1993 | EP0560633A1 Use of tropane derivatives for the manufacture of a medicament for the treatment of neurodegenerative diseases |
| 09/15/1993 | EP0560330A2 Substituted benzimidazolyl derivatives, therapeutic agents containing them and process for their preparation |
| 09/15/1993 | EP0560269A1 Substituted pyrrolidine derivatives as HIV protease inhibitors |
| 09/15/1993 | EP0560268A1 Substituted pipecolinic acid derivatives as HIV protease inhibitors |
| 09/15/1993 | EP0560163A1 Imidazolylmethyl substituted phenylacetic-acid amides, process for their preparation and their pharmaceutical application |
| 09/15/1993 | EP0559884A1 Viral recombinant vectors for expression in muscle cells |
| 09/15/1993 | EP0559812A1 Composition containing antihistamine h 2? receptor antagonists and bioadhesive material |
| 09/15/1993 | EP0559793A1 Hiv protease inhibitors |
| 09/15/1993 | EP0559769A1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 09/15/1993 | EP0559755A1 Substituted 5-aryl imidazoles |
| 09/15/1993 | EP0559751A1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth). |
| 09/15/1993 | EP0559724A1 Benzofuran and benzthiophene derivatives |
| 09/15/1993 | EP0517836A4 Method and product for promoting hair growth and treating skin conditions |
| 09/15/1993 | EP0419610B1 New leukotriene b4 derivatives, process for producing them and their use as drugs |
| 09/14/1993 | US5245061 Anticancer agents |
| 09/14/1993 | US5245035 Heterocyclic boron compounds as intermediates for angiotensin ii antagonists |
| 09/14/1993 | US5244912 Serotonin antagonist |
| 09/14/1993 | US5244911 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof |
| 09/14/1993 | US5244903 Camptothecin analogs as potent inhibitors of topoisomerase I |
| 09/14/1993 | US5244889 Treatment of cardiovascular disorders |
| 09/14/1993 | US5244883 Nonapeptide bombesin antagonists |
| 09/14/1993 | CA2091534A1 Method and composition for the treatment of osteoporosis |
| 09/14/1993 | CA2091434A1 Substituted phenylacetamides |
| 09/14/1993 | CA1322197C 9-halogen-(z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents |
| 09/14/1993 | CA1322164C Wound healing |
| 09/14/1993 | CA1322158C Uses of recombinant colony stimulating factor-1 |
| 09/14/1993 | CA1322156C Metal complex-containing pharmaceutical agents |
| 09/13/1993 | CA2091415A1 Substituted benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/09/1993 | DE4207254A1 4-oxo-2-thioxoimidazolidin-derivate 4-oxo-2-thioxoimidazolidin-derivatives |
| 09/08/1993 | EP0559414A1 Treatment of neurodegenerative diseases |
| 09/08/1993 | EP0559297A1 Use of heterocyclic derivatives for the manufacture of medicaments |
| 09/08/1993 | EP0559234A1 Monoclonal antibodies specific for an epitope in the B chain of platelet-derived growth factor and their use in affinity chromatography |
| 09/08/1993 | EP0559055A1 N-Deacetyl lysogangliosides for use as medicaments |
| 09/08/1993 | EP0558950A1 3-aryl-glycidic ester derivatives and process for their preparation |
| 09/08/1993 | EP0558753A1 Beta-glucuronidase inhibitor |
| 09/08/1993 | EP0558727A1 Bone-growth-stimulating composition |
| 09/08/1993 | EP0558681A1 Treatment for tissue ulceration |
| 09/08/1993 | EP0558659A1 Tnf inhibitors |
| 09/08/1993 | EP0558648A1 Improved matrix metalloprotease inhibitors |
| 09/08/1993 | EP0558630A1 Retroviral protease inhibitors |
| 09/08/1993 | EP0558603A1 Retroviral protease inhibitors |
| 09/08/1993 | EP0363402B1 Cyclopolygalacturonic acid composition and its use |
| 09/08/1993 | CN1075988A 多元溶剂清洗系统 Multiple solvent cleaning system |
| 09/08/1993 | CN1075970A Photocurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof |
| 09/08/1993 | CN1022023C Process for liquid pharmaceutical composition containing piperidinoalkanol derivatives |
| 09/07/1993 | US5243094 Derivatives of long chain fatty alcohols, their uses, particularly as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing them |
| 09/07/1993 | US5243054 Compound which is angiotensin ii antagonist |
| 09/07/1993 | US5242949 Treating classic migraine |
| 09/07/1993 | US5242945 Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors |
| 09/07/1993 | US5242937 Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors |
| 09/07/1993 | US5242934 Method for treatment of neurodegenerative diseases |
| 09/07/1993 | US5242929 Derivatives of substituted imidazol-2-one and process for their preparation |
| 09/07/1993 | US5242928 Angiotensin II antagonists |
| 09/07/1993 | US5242912 Cyclic anthranilic acid derivatives and process of preparing the same |
| 09/07/1993 | US5242909 Anticarcinogenic agents and antitumor agents |
| 09/07/1993 | CA2057021C Therapeutic application of an anti-invasion compound |
| 09/07/1993 | CA1322076C Phosphorus containing peptides |
| 09/07/1993 | CA1322005C Benzoheterazoles |
| 09/07/1993 | CA1322002C 2-(heteroaryliumalkyl)phenyl carbapenem antibacterial agents |
| 09/02/1993 | WO1993017118A2 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 09/02/1993 | WO1993017106A1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 09/02/1993 | WO1993017024A1 Triazolopyrimidin derivatives as antiotensin ii receptor antagonists |
| 09/02/1993 | WO1993017023A1 Pyrazolopyrimidin derivatives as angiotensin ii receptor antagonists |
| 09/02/1993 | WO1993017013A1 Quinolylbenzofuran derivatives as leukotriene antagonists |
| 09/02/1993 | WO1993017008A1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO[b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION |
| 09/02/1993 | WO1993017006A1 N-substituted-furylalkenyl hydroxamic acid and n-hydroxyurea compounds having lipoxygenase inhibitory activity |
| 09/02/1993 | WO1993016999A1 Benzodiazepin derivatives useful as cck-receptor antagonists |
| 09/02/1993 | WO1993016996A1 Indole derivatives as testosterone-5-alpha-reductase inhibitors |
| 09/02/1993 | WO1993016995A1 Process for preparing fibrinogen receptor antagonists |
| 09/02/1993 | WO1993016982A1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 09/02/1993 | WO1993016719A2 Use of platelet derived growth factor in ophthalmic wound healing |
| 09/02/1993 | WO1993016704A1 Method of inhibiting carcinogenesis by treatment with dehydroepiandrosterone and analogs thereof |
| 09/02/1993 | WO1993016703A1 Protein kinase c inhibitor |
| 09/02/1993 | WO1993016701A2 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
| 09/02/1993 | WO1993016695A1 Brofaromine as an agent for treating post-traumatic stress |
| 09/02/1993 | WO1993016690A1 Cytoprotective compositions containing pyruvate and antioxidants |
| 09/02/1993 | WO1993016674A1 CoA-IT AND PAF INHIBITORS |
| 09/02/1993 | CA2130748A1 Use of platelet derived growth factor in ophthalmic wound healing |
| 09/02/1993 | CA2129732A1 Cytoprotective compositions containing pyruvate and antioxidants |
| 09/02/1993 | CA2128998A1 Bicyclo¬2.2.2.|octane derivatives as cholestocystokinin inhibitors |
| 09/02/1993 | CA2128871A1 Pyrazolopyrimidin derivatives as angiotensin ii receptor antagonists |
| 09/02/1993 | CA2128701A1 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo¬b|-thiophene-2-carboxamides as inhibitors of cell adhesion |
| 09/02/1993 | CA2117607A1 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 09/02/1993 | CA2117430A1 Brofaromine as an agent for treating post-traumatic stress |
| 09/02/1993 | CA2117381A1 N-substituted-furylalkenyl hydroxamic acid and n-hydroxyurea compounds having lipoxygenase inhibitory activity |
| 09/01/1993 | EP0558468A1 Medicament for inhibiting nitric oxide formation |
| 09/01/1993 | EP0558443A1 O-Piperidyl-(3/4)-hydroxylamines and O-piperidyl-(3/4)-alkyl-hydroxylamines and their use as ornithine decarboxylase inhibitors |
| 09/01/1993 | EP0558139A1 Process for preparing fibrinogen receptor antagonists |